Broadly Neutralizing Influenza Hemagglutinin Stem-Specific Antibody CR8020 Targets Residues that Are Prone to Escape due to Host Selection Pressure
Broadly neutralizing antibodies (bNAb) that target a conserved region of a viral antigen hold significant therapeutic promise. CR8020 is a bNAb that targets the stem region of influenza A virus (IAV) hemagglutinin (HA). CR8020 is currently being evaluated for prophylactic use against group 2 IAVs in...
Main Authors: | , , , , |
---|---|
Other Authors: | , , , |
Format: | Article |
Language: | English |
Published: |
Elsevier,
2015-10-29T18:54:31Z.
|
Subjects: | |
Online Access: | Get fulltext |